GL1X · GenesisL1 explorer

MolNFT v1 · #181293 · protein

Structure of human MPS1 (ttk) covalently bound to rms-07 inhibitor

7LQD · Dual specificity protein kinase ttk or monopolar spindle 1…: “Structure of human MPS1 (ttk) covalently bound to rms-07 inhibitor”. X-ray diffraction, 2 ligands (YB4, TOE), 2 pockets (best druggability 0.69). MolNFT v1 #181293 on…

PDB
7LQD
Type
protein
Length
269 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase ttk or monopolar spindle 1 kinase
EC
2.7.12.1
Ligands
YB4, TOE
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity protein kinase ttk or monopolar spindle 1 kinase (EC 2.7.12.1)protein26938% helix, 20% strand—

Ligands and binding sites

  • YB4 · ~{N}-(2,6-diethylphenyl)-2-[[4-(4-methylpiperazin-1-yl)-2-(propanoylamino)phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide · ligand · chains A
  • TOE · 2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxyl · ligand · chains A
  • GOL · Glycerol · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14950.690.7942YB4, GOL, TOE
2510.270.7413empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7LQD · Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.